Background COVID-19 vaccines have been critical for protection against severe disease
following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but …

Background SARS-CoV-2 vaccination has proven the most effective measure to control the
COVID-19 pandemic. Booster doses are being administered with limited knowledge on their …

Background The relationship between postvaccination symptoms and strength of antibody
responses is unclear. The goal of this study was to determine whether adverse effects …

Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Current guidelines recommend that individuals who have had COVID-19 should receive the
identical vaccine regimen as those who have not had the infection. This includes two doses …

Abstract Background The SARS-CoV-2 pandemic was responsible for the death of millions
of people around the world, which accelerated the study of vaccines. The BNT162b2 mRNA …

Understanding the impact of prior infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to …

Assessing immune responses post-SARS-CoV-2 vaccination is crucial for optimizing
vaccine strategies. This prospective study aims to evaluate immune responses and …

Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) variants have been reported frequently in vaccinated individuals with waning immunity. In …

Background Safe and effective vaccines against COVID-19 are critical for preventing the
spread of SARS-CoV-2, but little is known about the humoral immune response more than 9 …